ASH Oral Presentation
The First-in-Human Dual BCMA and CD19 Targeted FasT CAR-T Cell Therapy for Multiple Myeloma Patients
12:15 PM EST, Saturday,December 5, 2020
Read More
NMPA IND approval to GC007g
Read More
Our passion is to expedite
novel cellular immunotherapy
from lab to bedside
Read More
ast CAR Dual CAR TruUCAR
Learn more about Gracell in real
time, industry news courier.
Press Releases
© 2019 Gracell All Rights Reserved 沪ICP备17053245号-1 Design by A+T
Language
中文